From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
2000–2004 (n = 74) | 2010–2014 (n = 154) | P | |
---|---|---|---|
Age (month) | 29.3 ± 24.8 | 26.9 ± 22.0 | 0.456 |
Sex (M/F) | 44/30 | 98/56 | 0.562 |
Fever (day) | |||
Preadmission | 5.5 ± 2.8 | 4.2 ± 1.5 | < 0.001 |
Total | 7.9 ± 3.9 | 6.0 ± 1.6 | < 0.001 |
Hospitalization (d) | 8.6 ± 4.5 | 5.6 ± 1.7 | < 0.001 |
Repeated IVIG, n (%) | 6 (8.1) | 7 (4.5) | 0.358 |
CALs, n (%) | 22 (29.7) | 24 (15.6) | 0.015 |
Ectasia | 19 (25.7) | 23 (14.9) | 0.067 |
Aneurysm | 3 (4.0) | 1 (0.6) | 0.102 |
WBC (/mm3) | 15,500 ± 5000 | 14,800 ± 4900 | 0.291 |
Neutrophil (%) | 60.5 ± 17.1 | 61.6 ± 14.8 | 0.599 |
Lymphocyte (%) | 24.9 ± 13.7 | 27.7 ± 11.7 | 0.116 |
Hemoglobin (g/dL) | 10.7 ± 0.8 | 11.4 ± 1.0 | < 0.001 |
Platelet (/mm3) | 324 ± 191 | 341 ± 108 | 0.010 |
Platelet, follow-up | 550 ± 291 | 418 ± 146 | < 0.001 |
CRP (mg/dL) | 10.4 ± 6.8 | 8.0 ± 4.9 | 0.008 |
ESR (mm/h) | 60 ± 23 | 70 ± 28 | < 0.001 |
Total protein (g/dL) | 6.4 ± 0.7 | 6.5 ± 0.6 | 0.703 |
Albumin (g/dL) | 3.5 ± 0.4 | 3.9 ± 0.5 | < 0.001 |
AST (IU/L) | 43 ± 39 | 96 ± 297 | 0.030 |
ALT (IU/L) | 65 ± 82 | 108 ± 174 | 0.021 |
ALT <40 IU, n (%) | 42 (56.8) | 81 (52.6) | 0.888 |
ALT 40–100 IU, n (%) | 18 (24.3) | 32 (20.8) | 0.616 |
ALT >100 IU, n (%) | 14 (18.9) | 41 (26.6) | 0.241 |